The Federal Government has appointed Dr. Monica Eimunjeze as the acting DG.
Recall President Muhammadu Buhari appointed Adeyeye in November 2017. The position’s five-year term is renewable.
A November 17 memo by Director of Human Resources Management, A. U. Oboli, informed units and departments of Adeyeye’s replacement.
The communication with reference number NAFDAC/ADM/SM/075 was addressed to the directors.
Oboli told them that the government had appointed Dr Monica Eimunjeze as the Acting Director-General with effect from November 12.
“I am therefore directed to bring this development to you for information and guidance,” she added.
The new head of the agency studied Pharmacy at Ahmadu Bello University (ABU) Zaria and graduated in 1986.
She obtained a Doctor of Pharmacy degree from Mercer University in Atlanta, and a Master of Science (MSc) in Biotechnology, Innovation and Regulatory Science from Purdue University.
Eimunjeze has years of experience in the pharmaceutical sector. She had her industrial exposure with GlaxoSmithKline from 1989 to 1996.
She was previously NAFDAC Director of Registration and Regulatory Affairs, Director of Drug Evaluation and Research, as well as Technical Assistant to the DG.